首页
期刊导航
期刊检索
论文检索
新闻中心
期刊
期刊
论文
首页
>
《癌症生物学与医学:英文版》
>
2017年4期
>
Thermogenic protein UCP1 and UCP3 expression in non- small cell lung cancer: relation with glycolysis and anaerobic metabolism
Thermogenic protein UCP1 and UCP3 expression in non- small cell lung cancer: relation with glycolysis and anaerobic metabolism
打印
分享
在线阅读
下载PDF
导出详情
摘要
未填写
DOI
pj0k67wx4y/1801899
作者
Alexandra Giatromanolaki;Konstantina Balaska;Dimitra Kalamida;Christos Kakouratos;Efthimios Sivridis;Michael I. Koukourakis
机构地区
不详
出处
《癌症生物学与医学:英文版》
2017年4期
关键词
分类
[医药卫生][肿瘤]
出版日期
2017年04月14日(中国期刊网平台首次上网日期,不代表论文的发表时间)
相关文献
1
单根法;钟竑;张辅贤;李国庆;隆桂麟;顾鹤定;戚晓敏.
Expression and Prognostic Significance of Multidrug Resistance Associated Protein (MRP) Gene in Non-small Cell Lung Cancer by in Site Hybridization
.肿瘤,2000-03.
2
林东;王恩华;张志坤;徐洪涛;李庆昌;邱雪杉.
EXPRESSION OF PHOSPHO-b-CATENIN AND ITS SIGNIFICANCE IN NON-SMALL CELL LUNG CANCER
.肿瘤,2003-01.
3
Zhou Fei,Zhou Cai-Cun.
Immunotherapy in non-small cell lung cancer: advancements and challenges
.医药卫生,2021-05.
4
Mari Mino-Kenudson.
Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
.肿瘤,2016-02.
5
Rongna Ma;Nannan Feng;Xiao Yu;Hongyan Lin;Xiaohong Zhang;Oumin Shi;Huan Zhang;Shuo Zhang;Lei Li;Min Zheng;Ming Gao;Herbert Yu;Biyun Qian.
Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non- small cell lung cancer
.肿瘤,2017-04.
6
Lin Jiang,Jingbo Zhang,Yan Xu,Heng Xu,Mengzhao Wang.
Treating non-small cell lung cancer by targeting the PI3K signaling pathway
.医药卫生,2022-12.
7
Li Chu-Ling,Song Yong.
Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
.医药卫生,2021-09.
8
Yu-Sook Jeong;Hye-Suk Han;Sung-Nam Lim;Mi-Jin Kim;Joung-Ho Han;Min-Ho Kang;Dong-Hee Ryu;Ok-Jun Lee;Ki-Hyeong Lee;Seung-Taik Kim.
Gallbladder Metastasis of Non-small Cell Lung Cancer Presenting as Acute Cholecystitis
.肿瘤,2012-03.
9
Xu Jia-Li,Wang Xin-Zhu,Jiang Hu-Ning,Chen Yi,Wang Rong,Shu Yong-Qian.
Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
.医药卫生,2020-11.
10
Siyuan Ren,Mengyao Ma,Chuan He,Yuhui Deng,Xiaoyun Chen,Yonglin Liu,Yangyang Jin,Yansong Liu,Lei Cai,Lin He.
Placebo effect in the treatment of non-small cell lung cancer: a meta-analysis
.医药卫生,2022-12.
来源期刊
癌症生物学与医学:英文版
2017年4期
相关推荐
The earlier, the better? A review of neoadjuvant immunotherapy in resectable non-small-cell lung cancer
3-59 Mechanism on X-ray Irradiation Suppressing Radioresistance in Non-small Cell Lung Cancer
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL SURGERYFOR NON-SMALL CELL LUNG CANCER:A RANDOMIZED STUDY
Recombinant human erythropoietin accelerated the proliferation of non-small cell lung cancer cell lines and reduced the expression of VEGF, HIF-1α, and PD-L1 under a simulated hypoxic environment in vitro
同分类资源
更多
[肿瘤]
动力外固定架结合克氏针治疗桡骨远端不稳定型骨折
[肿瘤]
先天性脊柱侧凸伴高肩胛症的临床评估与手术
[肿瘤]
医者寄语
[肿瘤]
小肠
[肿瘤]
中晚期食管癌患者血浆PAI-1水平及其临床意义
相关关键词
返回顶部